Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold?

EuroIntervention

Volumn 12, Issue 8, 2016, Pages e998-e1008

  Sotomi, Yohei ^a   Onuma, Yoshinobu ^b,c   Suwannasom, Pannipa ^a,b,d   Tateishi, Hiroki ^b   Tenekecioglu, Erhan ^b   Zeng, Yaping ^b   Cavalcante, Rafael ^b   Jonker, Hans ^c   Dijkstra, Jouke ^e   Foin, Nicolas ^f   Koon, Jaryl Ng Chen ^f   Collet, Carlos ^a   De Winter, Robbert J ^a   Wykrzykowska, Joanna J ^a   Stone, Gregg W ^g   Popma, Jeffrey J ^h   Kozuma, Ken ⁱ   Tanabe, Kengo ^j   Serruys, Patrick W ^k   Kimura, Takeshi ^l  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CARDIALYSIS   (Netherlands)

^d Faculty of Medicine Chiang Mai University   (Thailand)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f DEPARTMENT OF CARDIOLOGY   (Singapore)

^g Department of Medicine   (United States)

^h BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

ⁱ TEIKYO UNIVERSITY HOSPITAL   (Japan)

^j MITSUI MEMORIAL HOSPITAL   (Japan)

^k IMPERIAL COLLEGE LONDON   (United Kingdom)

^l KYOTO UNIVERSITY HOSPITAL   (Japan)

more..

Author keywords

Measurement discrepancy; Metallic stent; Optical coherence tomography; Polymeric scaffold; Quantitative coronary angiography

Indexed keywords

AGED; ARTICLE; BIORESORBABLE SCAFFOLD; CARDIOVASCULAR PARAMETERS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CROSS-SECTIONAL STUDY; EVEROLIMUS ELUTING CORONARY STENT; FEMALE; HUMAN; INTRAVASCULAR ULTRASOUND; JAPAN; LUMEN DIAMETER; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; METAL STENT; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; PROSPECTIVE STUDY; QUANTITATIVE CORONARY ANGIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SINGLE BLIND PROCEDURE; BIODEGRADABLE IMPLANT; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIAGNOSTIC IMAGING; DRUG ELUTING STENT; MIDDLE AGED; PROCEDURES; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIAL (TOPIC); TISSUE SCAFFOLD; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENT; EVEROLIMUS; POLYESTER; POLYLACTIDE;

ABSORBABLE IMPLANTS; AGED; ANTINEOPLASTIC AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; EVEROLIMUS; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYESTERS; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SINGLE-BLIND METHOD; TISSUE SCAFFOLDS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84994613857     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV12I8A163     Document Type: Article

References (19)

1. Gutierrez-Chico JL, Serruys PW, Girasis C, Garg S, Onuma Y, Brugaletta S, Garcia-Garcia H, van Es GA, Regar E. Quantitative multi-modality imaging analysis of a fully bioresorbable stent: a head-to-head comparison between QCA, IVUS and OCT. Int J Cardiovasc Imaging. 2012;28:467-78.
2. Nakatani S, Sotomi Y, Ishibashi Y, Grundeken MJ, Tateishi H, Tenekecioglu E, Zeng Y, Suwannasom P, Regar E, Radu MD, Raber L, Bezerra H, Costa MA, Fitzgerald P, Prati F, Costa RA, Dijkstra J, Kimura T, Kozuma K, Tanabe K, Akasaka T, Di Mario C, Serruys PW, Onuma Y. Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up. EuroIntervention. 2015 Oct 9;11(6). [Epub ahead of print].
3. Kimura T, Kozuma K, Tanabe K, Nakamura S, Yamane M, Muramatsu T, Saito S, Yajima J, Hagiwara N, Mitsudo K, Popma JJ, Serruys PW, Onuma Y, Ying S, Cao S, Staehr P, Cheong WF, Kusano H, Stone GW. A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. Eur Heart J. 2015;36:3332-42.
4. Sabate M, Windecker S, Iniguez A, Okkels-Jensen L, Cequier A, Brugaletta S, Hofma SH, Raber L, Christiansen EH, Suttorp M, Pilgrim T, Anne van Es G, Sotomi Y, Garcia-Garcia HM, Onuma Y, Serruys PW. Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial. Eur Heart J. 2016;37:229-40.
5. Okamura T, Onuma Y, Garcia-Garcia HM, van Geuns RJ, Wykrzykowska JJ, Schultz C, van der Giessen WJ, Ligthart J, Regar E, Serruys PW. First-in-man evaluation of intravascular optical frequency domain imaging (OFDI) of Terumo: a comparison with intravascular ultrasound and quantitative coronary angiography. EuroIntervention. 2011;6:1037-45.
6. Strauss BH, Rensing BJ, den Boer A, van der Giessen WJ, Reiber JH, Serruys PW. Do stents interfere with the densitometric assessment of a coronary artery lesion? Cathet Cardiovasc Diagn. 1991;24:259-64.
7. Koskinas KC, Chatzizisis YS, Antoniadis AP, Giannoglou GD. Role of endothelial shear stress in stent restenosis and thrombosis: pathophysiologic mechanisms and implications for clinical translation. J Am Coll Cardiol. 2012;59:1337-49.
8. Serruys PW, Suwannasom P, Nakatani S, Onuma Y Snowshoe Versus Ice Skate for Scaffolding of Disrupted Vessel Wall. JACC Cardiovasc Interv. 2015;8:910-3.
9. Tsuchida K, Garcia-Garcia HM, Ong AT, Valgimigli M, Aoki J, Rademaker TA, Morel MA, van Es GA, Bruining N, Serruys PW. Revisiting late loss and neointimal volumetric measurements in a drug-eluting stent trial: analysis from the SPIRIT FIRST trial. Catheter Cardiovasc Interv. 2006;67: 188-97.
10. Bruining N, Tanimoto S, Otsuka M, Weustink A, Ligthart J, de Winter S, van Mieghem C, Nieman K, de Feyter PJ, van Domburg RT, Serruys PW. Quantitative multi-modality imaging analysis of a bioabsorbable poly-L-lactic acid stent design in the acute phase: a comparison between 2-and 3D-QCA, QCU and QMSCT-CA. EuroIntervention. 2008;4:285-91.
11. Sotomi Y, Tateishi H, Suwannasom P, Dijkstra J, Eggermont J, Liu S, Tenekecioglu E, Zheng Y, Abdelghani M, Cavalcante R, de Winter RJ, Wykrzykowska JJ, Onuma Y, Serruys PW, Kimura T. Quantitative assessment of the stent/scaffold strut embedment ana lysis by optical coherence tomography. Int J Cardiovasc Imaging. 2016;32:871-83.
12. Bezerra HG, Attizzani GF, Sirbu V, Musumeci G, Lortkipanidze N, Fujino Y, Wang W, Nakamura S, Erglis A, Guagliumi G, Costa MA. Optical coherence tomography versus intravascular ultrasound to evaluate coronary artery disease and percutaneous coronary intervention. JACC Cardiovasc Interv. 2013;6:228-36.
13. Kubo T, Akasaka T, Shite J, Suzuki T, Uemura S, Yu B, Kozuma K, Kitabata H, Shinke T, Habara M, Saito Y, Hou J, Suzuki N, Zhang S. OCT compared with IVUS in a coronary lesion assessment: the OPUS-CLASS study. JACC Cardiovasc Imaging. 2013;6:1095-104.
14. O'Brien BJ, Stinson JS, Larsen SR, Eppihimer MJ, Carroll WM. A platinum-chromium steel for cardiovascular stents. Biomaterials. 2010;31:3755-61.
15. Jimenez JM, Davies PF. Hemodynamically driven stent strut design. Ann Biomed Eng. 2009;37:1483-94.
16. Teresa Parra, Ruben Perez, Miguel A. Rodriguez, Francisco Castro, Robert Z. Szasz, Artur Gutkowski. Numerical Simulation of Swirling Flows-Heat Transfer Enhancement. Journal of Fluid Flow, Heat and Mass Transfer. 2015;2:1-6.
17. Serruys PW, Chevalier B, Dudek D, Cequier A, Carrie D, Iniguez A, Dominici M, van der Schaaf RJ, Haude M, Wasungu L, Veldhof S, Peng L, Staehr P, Grundeken MJ, Ishibashi Y, Garcia-Garcia HM, Onuma Y. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial. Lancet. 2015;385:43-54.
18. Foin N, Gutierrez-Chico JL, Nakatani S, Torii R, Bourantas CV, Sen S, Nijjer S, Petraco R, Kousera C, Ghione M, Onuma Y, Garcia-Garcia HM, Francis DP, Wong P, Di Mario C, Davies JE, Serruys PW. Incomplete stent apposition causes high shear flow disturbances and delay in neointimal coverage as a function of strut to wall detachment distance: implications for the man-agement of incomplete stent apposition. Circ Cardiovasc Interv. 2014;7:180-9.
19. Serruys PW, Onuma Y, Ormiston JA, de Bruyne B, Regar E, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Miquel-Hebert K, Rapoza R, Garcia-Garcia HM. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation. 2010;122: 2301-12.